Shanghai Xuerong Biotechnology300511.SZValuation Analysis

As of Oct 19, 2026, Shanghai Xuerong Biotechnology (300511.SZ) trades at a P/E of 19.40x, P/B of 1.79x, P/S of 1.26x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 26th percentile over the trailing 10Y window (vs. 32nd percentile over 3Y); P/B sits at the 25th percentile over the trailing 10Y window (vs. 35th percentile over 3Y); P/S sits at the 19th percentile over the trailing 10Y window (vs. 48th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 18th percentile within its industry and the 23rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Cross-checking P/E against P/B, the two percentiles sit within 0.7 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Shanghai Xuerong Biotechnology operates in the Agriculture, Forestry, Animal Husbandry and Fishery sector. Data refreshes weekly and is for reference only, not investment advice.